Document is current
Any future updates will be listed below
-
Authors
Chen, Xiaochuan
Jiang, Zhangying
Pan, Junping
Xu, Wenqian
Li, Ying
Chen, Xin
Pan, Yuhui
Weng, Youliang
Hu, Dan
Qiu, Sufang
-
Funding
Funding for this research was provided by:
The Qihang Funds of Fujian Medical Universit (2022QH2049)
Joint Funds for the Innovation of Science and Technology, Fujian province (2023Y9436)
Fujian Provincial Clinical Research Center for Cancer Radiotherapy and Immunotherapy (2020Y2012)
National Natural Science Foundation of China (11974077)
Major Research Projects for Young and Middle-aged Researchers of Fujian Provincial Health Commission (2021ZQNZD010)
Joint Funds for the innovation of science and Technology, Fujian province (2021Y9196)
- License Information
-
More Information
Article History
Received: 14 September 2024
Accepted: 20 March 2025
First Online: 24 April 2025
Declarations
:
: This study was authorized by the ethics committee of Fujian Cancer Hospital (Fuzhou, China; numbers K2022-084-01). Authors confirmed that all experiments on the use of human tissue samples were performed in accordance with relevant guidelines and regulations. Each patient was asked to grant their written and informed consent before participating in any study-specific research.
: Not applicable.
: The authors declare no competing interests.
